4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-071671
President and General Counsel sold 16,630 shares at $22.44 ($373,177)
- President and General Counsel acquired 16,630 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2018-12-03 | Option exercise | +16,630 | $10.48 | $174,282 | 200,445 | D |
| Shandell Jason B. President and General Counsel | 2018-12-03 | Sale | −16,630 | $22.44 | $373,177 | 183,815 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2018-12-03 | Option exercise · Employee Stock Option (right to buy) | −16,630 | 0 | D | ||
| Open-market sales · 16,630 sh · avg $22.44 · $373,177 | |||||||
Loading xslF345X03/a4.xml…